About LipoScience
LipoScience is a highly innovative, diagnostic company focused on changing the way heart disease, diabetes* and other metabolic diseases are assessed and managed.
We develop proprietary tests based on Nuclear Magnetic Resonance (NMR), an information-rich technology that produces a digital representation of the molecules present in a simple blood sample.
Over 5 million NMR LipoProfile® tests have been ordered by physicians. This test directly measures lipoprotein particles and provides physicians and their patients more information to manage their risk for heart disease and diabetes.
The company is preparing to decentralize its proprietary platform with a broad array of high value NMR based assays, in support of driving toward new clinical standards of care.
We have broad opportunities for growth in our diagnostic, research, and laboratory businesses. We are actively pursuing these opportunities with the support of our employees, our customers, and our industry partners.
* The LP-IR test is only available through the LipoScience laboratory.
News
-
August 2010
LipoScience performs its 5 millionth NMR LipoProfile test! -
August 2010
Medical News Today and Endocrine Today run articles on the benefits of lipoprotein testing and type 2 diabetes in women. -
August 4 - 6, 2010
LipoScience will be exhibiting at the Association of Diabetes Educators (AADE) in San Antonio TX, Booth 6180. -
August 2010
Enhance Magazine features the NMR LipoProfile test in their summer issue, which discusses the role of lipoprotein particles in the assessment and management of CVD. Navigating the Health Highway, Enhance Magazine, 2010:44-51. -
August 10, 2010
Richard O. Brajer, President and CEO, will be presenting at the Canaccord Genuity 30th Annual Growth Conference in Boston, MA. -
September 15, 2010
Richard O. Brajer, President and CEO, will be presenting at the Baird's 2010 Health Conference in New York, NY.





